Literature DB >> 16392229

A successful anticoagulation protocol for the first HeartMate II implantation in the United States.

Offer Amir1, Arthur W Bracey, Frank W Smart, Reynolds M Delgado, Nyma Shah, Biswajit Kar.   

Abstract

Bleeding and thrombus formation are common problems with life-threatening implications in patients receiving a left ventricular assist device. We describe the anticoagulation protocol for the 1st patient in the United States to undergo successful implantation of the HeartMate II left ventricular assist system.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16392229      PMCID： PMC1336719     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN： 0730-2347


  7 in total

Review 1.  Hemostatic product transfusions and adverse outcomes: focus on point-of-care testing to reduce transfusion need.

Authors:  S von Kier; A Smith
Journal:  J Cardiothorac Vasc Anesth       Date:  2000-06       Impact factor: 2.628

2.  Effect of low-molecular weight dextran sulfate on coagulation and platelet function tests.

Authors:  Sacha Zeerleder; Thomas Mauron; Bernhard Lämmle; Walter A Wuillemin
Journal:  Thromb Res       Date:  2002-03-01       Impact factor: 3.944

Review 3.  Left ventricular assist devices and bleeding: adding insult to injury.

Authors:  Daniel J Goldstein; Robert B Beauford
Journal:  Ann Thorac Surg       Date:  2003-06       Impact factor: 4.330

4.  Arizona experience with CardioWest Total Artificial Heart bridge to transplantation.

Authors:  J G Copeland; F A Arabia; R G Smith; G K Sethi; P E Nolan; M E Banchy
Journal:  Ann Thorac Surg       Date:  1999-08       Impact factor: 4.330

5.  Frequency, risk factors, and clinical outcomes of left ventricular assist device-associated ventricular thrombus.

Authors:  M P Reilly; S E Wiegers; A J Cucchiara; M L O'Hara; T J Plappert; E Loh; M A Acker; M St John Sutton
Journal:  Am J Cardiol       Date:  2000-11-15       Impact factor: 2.778

6.  Thromboelastography-guided transfusion algorithm reduces transfusions in complex cardiac surgery.

Authors:  L Shore-Lesserson; H E Manspeizer; M DePerio; S Francis; F Vela-Cantos; M A Ergin
Journal:  Anesth Analg       Date:  1999-02       Impact factor: 5.108

7.  Coagulation monitoring and management of anticoagulation during cardiac assist device support.

Authors:  Dietmar Fries; Petra Innerhofer; Werner Streif; Wolfgang Schobersberger; Josef Margreiter; Herwig Antretter; Christoph Hörmann
Journal:  Ann Thorac Surg       Date:  2003-11       Impact factor: 4.330
  7 in total
  4 in total

Review 1.  Antithrombotic therapy for the CardioWest temporary total artificial heart.

Authors:  Christopher R Ensor; William D Cahoon; Michael A Crouch; Gundars J Katlaps; Michael L Hess; Richard H Cooke; Kyle J Gunnerson; Vigneshwar Kasirajan
Journal:  Tex Heart Inst J       Date:  2010

Review 2.  Ventricular assist devices: pharmacological aspects of a mechanical therapy.

Authors:  O Wever-Pinzon; J Stehlik; A G Kfoury; J V Terrovitis; N A Diakos; C Charitos; D Y Li; S G Drakos
Journal:  Pharmacol Ther       Date:  2012-01-16       Impact factor: 12.310

3.  Antibacterial Biomimetic Hybrid Films.

Authors:  M Carme Coll Ferrer; Noreen J Hickok; David M Eckmann; Russell J Composto
Journal:  Soft Matter       Date:  2013-02-28       Impact factor: 3.679

4.  Early thrombus in a HeartMate II left ventricular assist device: a potential cause of hemolysis and diagnostic dilemma.

Authors:  Castigliano M Bhamidipati; Gorav Ailawadi; James Bergin; John A Kern
Journal:  J Thorac Cardiovasc Surg       Date:  2009-11-27       Impact factor: 5.209
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.